321 related articles for article (PubMed ID: 18067554)
1. CD22: an inhibitory enigma.
Walker JA; Smith KG
Immunology; 2008 Mar; 123(3):314-25. PubMed ID: 18067554
[TBL] [Abstract][Full Text] [Related]
2. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
3. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
4. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.
Enterina JR; Jung J; Macauley MS
Biomed J; 2019 Aug; 42(4):218-232. PubMed ID: 31627864
[TBL] [Abstract][Full Text] [Related]
5. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
Ghosh S; Bandulet C; Nitschke L
Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
[TBL] [Abstract][Full Text] [Related]
6. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
7. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation.
Courtney AH; Puffer EB; Pontrello JK; Yang ZQ; Kiessling LL
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2500-5. PubMed ID: 19202057
[TBL] [Abstract][Full Text] [Related]
8. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
[TBL] [Abstract][Full Text] [Related]
9. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
[TBL] [Abstract][Full Text] [Related]
10. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
11. N-Linked Glycosylation Regulates CD22 Organization and Function.
Wasim L; Buhari FHM; Yoganathan M; Sicard T; Ereño-Orbea J; Julien JP; Treanor B
Front Immunol; 2019; 10():699. PubMed ID: 31019513
[TBL] [Abstract][Full Text] [Related]
12. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
13. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.
Clark EA; Giltiay NV
Front Immunol; 2018; 9():2235. PubMed ID: 30323814
[TBL] [Abstract][Full Text] [Related]
14. Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.
Bednar KJ; Shanina E; Ballet R; Connors EP; Duan S; Juan J; Arlian BM; Kulis MD; Butcher EC; Fung-Leung WP; Rao TS; Paulson JC; Macauley MS
J Immunol; 2017 Nov; 199(9):3116-3128. PubMed ID: 28972089
[TBL] [Abstract][Full Text] [Related]
15. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
Tsubata T
Front Immunol; 2018; 9():2276. PubMed ID: 30333834
[TBL] [Abstract][Full Text] [Related]
16. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
17. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
Haas KM; Johnson KL; Phipps JP; Do C
J Immunol; 2018 Mar; 200(5):1671-1681. PubMed ID: 29374074
[TBL] [Abstract][Full Text] [Related]
18. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling.
Collins BE; Smith BA; Bengtson P; Paulson JC
Nat Immunol; 2006 Feb; 7(2):199-206. PubMed ID: 16369536
[TBL] [Abstract][Full Text] [Related]
19. Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells.
Meyer SJ; Böser A; Korn MA; Koller C; Bertocci B; Reimann L; Warscheid B; Nitschke L
J Immunol; 2020 Jun; 204(12):3360-3374. PubMed ID: 32341059
[TBL] [Abstract][Full Text] [Related]
20. CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling.
Müller J; Obermeier I; Wöhner M; Brandl C; Mrotzek S; Angermüller S; Maity PC; Reth M; Nitschke L
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12402-7. PubMed ID: 23836650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
